News | Radiation Oncology | May 18, 2023

The new partnership is set to expand availability of a revolutionary new technology

Cassling announced it is a new strategic sales agent in various geographic territories across the United States for Radiaction Medical, the makers of a novel, FDA-cleared advanced radiation blocking technology.

May 18, 2023 — Cassling announced it is a new strategic sales agent in various geographic territories across the United States for Radiaction Medical, the makers of a novel, FDA-cleared advanced radiation blocking technology.

The Radiaction system is the first and only advanced technology to proactively block radiation at the source, providing comprehensive, head-to-toe radiation protection to the entire interventional team. Radiaction provides an unparalleled level of protection to physicians and staff while allowing unencumbered patient care, access and service.

“Radiaction is a natural fit for a partnership with Cassling,” said Elizabeth Grieger, VP of Growth and Innovation at Cassling. “For nearly 40 years, our hospital partners, including interventional suites and catheterization labs that enhance patient outcomes, have trusted us to connect them to state-of-the-art systems.”

Grieger continued, “When we met with Radiaction, we recognized how its technology is truly a revolution in what we can do to protect providers in these settings. I’m excited that we can provide our customers with an advanced solution that is designed to protect the treating physicians, as well as everyone in the procedure room. Radiaction seamlessly integrates into procedural workflow, giving providers the protection they deserve while still enabling them to do their best work for patients.”

Traditionally, procedures completed in interventional suites and catheterization labs have required physicians and other team members in the vicinity of the patient to don heavy lead aprons to protect themselves from radiation scatter. While a good start, lead gowns still provide gaps in radiation protection and leave key areas of the body, such as the head, face, legs and arms exposed.

Radiaction’s device, however, provides full-body protection. As an accessory to existing C-arm imaging equipment, Radiaction blocks more than 90% of scatter radiation to the entire room, with up to 97% radiation scatter protection for the physician’s head, according to clinical studies. The device fully encapsulates the imaging X-ray beam, and at the touch of a button, the system dynamically deploys or retracts within seconds, accommodating any patient size, imaging angulation or location while enabling the team to maintain immediate access to their patients throughout the procedure.

Jonathan Yifat, Radiaction Medical’s CEO, is excited about the partnership’s potential: “When we seek industry partners for a collaborative effort, capabilities are important, but shared corporate values are the best indicator of a productive relationship,” he said, adding, “Cassling’s deep commitment to improving the workplace experience and safety of frontline healthcare providers makes them an obvious choice for us. We are especially eager to work with them to introduce the groundbreaking Radiaction technology to Cassling’s customers, to protect and serve the people who care for patients.”

Radiaction has received 510(k) clearance from the Food and Drug Administration (FDA) to enable compatibility with certain C-arm machines. As part of an initial agreement, Cassling will offer the system to cardiology lab customers throughout the country.

For more information: www.cassling.com

Related Radiation Scatter Content:

Radiation Scatter 101: Risks, Dangers and Latest Solutions

Radiaction Medical Announces the Latest Food and Drug Administration 510(k) Clearance for its Novel, Automated Radiation Shield System, Highlighting U.S. Expansion

Market for MRI-based Radiotherapy Could Soon Widen

Carestream Introduces SmartGrid Software to Reduce Effects of Scatter Radiation

Scatter Radiation from Mammography Presents No Cancer Risk


Related Content

News | Radiation Therapy

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
News | FDA

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
News | Lung Imaging

April 17, 2024 — A Medicare policy requiring primary care providers (PCPs) to share in the decision-making with patients ...

Time April 17, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Radiation Therapy

April 12, 2024 — RTsafe, a leading provider of quality assurance products and services in stereotactic radiosurgery, and ...

Time April 12, 2024
arrow
News | Artificial Intelligence

April 9, 2024 —PreciseDx, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for ...

Time April 09, 2024
arrow
News | Artificial Intelligence

April 8, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...

Time April 08, 2024
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

Here is a snapshot of the Top 10 most-read content from ITN's viewers during the month of March: 1. Philips Teams with ...

Time April 04, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
Subscribe Now